| PDAC | Pancreatic ductal adenocarcinoma |
| GEM | Gemcitabine |
| NAB | Nabpaclitaxel |
| HP-β-CD | Hydroxy-Propil-β-Cyclodextrin |
| CDs | Cyclodextrins |
| MTAs | Microtubule targeting agents |
| FDA | Food and Drug Administration |
| FACS | Fluorescence-Activated Cell Sorter |
| PDAC | Pancreatic ductal adenocarcinoma |
| GEM | Gemcitabine |
| NAB | Nabpaclitaxel |
| HP-β-CD | Hydroxy-Propil-β-Cyclodextrin |
| CDs | Cyclodextrins |
| MTAs | Microtubule targeting agents |
| FDA | Food and Drug Administration |
| FACS | Fluorescence-Activated Cell Sorter |